NuCana
NCNA
#11102
Rank
A$5.99 M
Marketcap
A$1.44
Share price
-2.88%
Change (1 day)
-76.08%
Change (1 year)

Earnings for NuCana (NCNA)

Earnings in 2026 (TTM): -A$28.72 Million

According to NuCana 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$40.22 Million, an increase over its 2024 earnings that were of -A$41.99 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NuCana from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$28.72 Million-28.59%
2025 -A$40.22 Million-4.23%
2024 -A$41.99 Million-24.16%
2023 -A$55.37 Million-27.12%
2022 -A$75.97 Million-13.88%
2021 -A$88.21 Million45.6%
2020 -A$60.59 Million29.44%
2019 -A$46.81 Million12.74%
2018 -A$41.52 Million-8.89%
2017 -A$45.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.23 Billion 700.08%๐Ÿ‡บ๐Ÿ‡ธ USA